Aurora Cannabis (ACB) Amortizatization of Intangibles (2017 - 2025)
Aurora Cannabis (ACB) posted quarterly Amortizatization of Intangibles of -$117778.9 for Q1 2025, down 234.5% year-on-year from $87569.4 in Q1 2024, and down 233.76% on a QoQ basis from $88049.4 in Q4 2024.
Aurora Cannabis (ACB) Amortizatization of Intangibles (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has reported Amortizatization of Intangibles for 9 consecutive years, with -$117778.9 the latest figure, recorded in Q1 2025.
- Quarterly Amortizatization of Intangibles fell 234.5% year-over-year to -$117778.9 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $234698.2 (down 96.62% YoY) and the FY2026 annual result came in at $584676.6, up 158.02% from the prior year.
- Amortizatization of Intangibles eased to -$117778.9 in Q1 2025 per ACB's latest filing, from $88049.4 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for ACB reached as high as $8.8 million in Q2 2021 and fell as low as -$117778.9 in Q1 2025.
- A 5-year average of $3.7 million and a median of $6.5 million in 2022 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2021 — Amortizatization of Intangibles rose 28.95% — and 2025, when it sank 234.5%.
- Year by year, Amortizatization of Intangibles stood at $6.7 million in 2021, then slipped by 2.95% to $6.5 million in 2022, then sank by 97.0% to $193917.4 in 2023, then sank by 54.59% to $88049.4 in 2024, then tumbled by 233.76% to -$117778.9 in 2025.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered -$117778.9, $88049.4, and $186195.6 for Q1 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Aurora Cannabis | 155.40 Mn | 70.15 Mn | 21.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -117,778.88 |
| Mar 31, 2025 | -117,778.88 |
| Dec 31, 2024 | 88,049.44 |
| Dec 31, 2024 | 88,049.44 |
| Sep 30, 2024 | 186,195.57 |
| Sep 30, 2024 | 186,195.57 |
| Jun 30, 2024 | 78,232.04 |
| Jun 30, 2024 | 78,232.04 |
| Mar 31, 2024 | 87,569.36 |
| Mar 31, 2024 | 87,569.36 |
| Dec 31, 2023 | 193,917.38 |
| Dec 31, 2023 | 193,917.38 |
| Sep 30, 2023 | 204,384.95 |
| Sep 30, 2023 | 204,384.95 |
| Dec 31, 2022 | 6.46 Mn |
| Dec 31, 2022 | 6.46 Mn |
| Sep 30, 2022 | 6.52 Mn |
| Sep 30, 2022 | 6.52 Mn |
| Jun 30, 2022 | 6.52 Mn |
| Jun 30, 2022 | 6.52 Mn |